Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Randall W. King, M.D., Ph.D.

TitleHarry C. McKenzie Professor of Cell Biology
InstitutionHarvard Medical School
DepartmentCell Biology
AddressHarvard Medical School
Department of Cell Biology, C2-666
240 Longwood Ave
Boston MA 02115
Phone617/432-3629
Fax617/432-6424

 Mentoring 
 completed student projects
Ubiquitination in Xenopus egg extract
Summer, 06/01/06 - 08/31/06

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Lim HJ, Dimova NV, Tan MK, Sigoillot FD, King RW, Shi Y. The G2/M Regulator Histone Demethylase PHF8 Is Targeted for Degradation by the Anaphase-Promoting Complex Containing CDC20. Mol Cell Biol. 2013 Nov; 33(21):4166-80.
    View in: PubMed
  2. Pfaff KL, King RW. Determinants of human cyclin b1 association with mitotic chromosomes. PLoS One. 2013; 8(3):e59169.
    View in: PubMed
  3. Lee BH, Finley D, King RW. A High-Throughput Screening Method for Identification of Inhibitors of the Deubiquitinating Enzyme USP14. Curr Protoc Chem Biol. 2012 Dec 1; 4(4):311-30.
    View in: PubMed
  4. Zeng X, King RW. An APC/C inhibitor stabilizes cyclin B1 by prematurely terminating ubiquitination. Nat Chem Biol. 2012 Apr; 8(4):383-92.
    View in: PubMed
  5. Adamson B, Smogorzewska A, Sigoillot FD, King RW, Elledge SJ. A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat Cell Biol. 2012 Mar; 14(3):318-28.
    View in: PubMed
  6. Sigoillot FD, Lyman S, Huckins JF, Adamson B, Chung E, Quattrochi B, King RW. A bioinformatics method identifies prominent off-targeted transcripts in RNAi screens. Nat Methods. 2012 Apr; 9(4):363-6.
    View in: PubMed
  7. Dimova NV, Hathaway NA, Lee BH, Kirkpatrick DS, Berkowitz ML, Gygi SP, Finley D, King RW. APC/C-mediated multiple monoubiquitylation provides an alternative degradation signal for cyclin B1. Nat Cell Biol. 2012 Feb; 14(2):168-76.
    View in: PubMed
  8. Sigoillot FD, Huckins JF, Li F, Zhou X, Wong ST, King RW. A time-series method for automated measurement of changes in mitotic and interphase duration from time-lapse movies. PLoS One. 2011; 6(9):e25511.
    View in: PubMed
  9. Miduturu CV, Deng X, Kwiatkowski N, Yang W, Brault L, Filippakopoulos P, Chung E, Yang Q, Schwaller J, Knapp S, King RW, Lee JD, Herrgard S, Zarrinkar P, Gray NS. High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors. Chem Biol. 2011 Jul 29; 18(7):868-79.
    View in: PubMed
  10. Harper JW, King RW. Stuck in the middle: drugging the ubiquitin system at the e2 step. Cell. 2011 Jun 24; 145(7):1007-9.
    View in: PubMed
  11. Krajcovic M, Johnson NB, Sun Q, Normand G, Hoover N, Yao E, Richardson AL, King RW, Cibas ES, Schnitt SJ, Brugge JS, Overholtzer M. A non-genetic route to aneuploidy in human cancers. Nat Cell Biol. 2011 Mar; 13(3):324-30.
    View in: PubMed
  12. Sigoillot FD, King RW. Vigilance and validation: Keys to success in RNAi screening. ACS Chem Biol. 2011 Jan 21; 6(1):47-60.
    View in: PubMed
  13. Zeng X, Sigoillot F, Gaur S, Choi S, Pfaff KL, Oh DC, Hathaway N, Dimova N, Cuny GD, King RW. Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell. 2010 Oct 19; 18(4):382-95.
    View in: PubMed
  14. Lee BH, Lee MJ, Park S, Oh DC, Elsasser S, Chen PC, Gartner C, Dimova N, Hanna J, Gygi SP, Wilson SM, King RW, Finley D. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature. 2010 Sep 9; 467(7312):179-84.
    View in: PubMed
  15. Lee MJ, Lee BH, Hanna J, King RW, Finley D. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol Cell Proteomics. 2011 May; 10(5):R110.003871.
    View in: PubMed
  16. Normand G, King RW. Understanding cytokinesis failure. Adv Exp Med Biol. 2010; 676:27-55.
    View in: PubMed
  17. King RW. When 2+2=5: the origins and fates of aneuploid and tetraploid cells. Biochim Biophys Acta. 2008 Sep; 1786(1):4-14.
    View in: PubMed
  18. Normand G, King RW. Understanding Cytokinesis Failure. Polyploidization and Cancer, Randy Poon, Ed. 2008; In press.
  19. King, RW. When 2+2=5: The Origins and Fates of Aneuploid and Tetraploid Cells. Biochem Biophys Acta Reviews on Cancer. 2008; In press.
  20. Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW, Cibas ES, Brugge JS. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell. 2007 Nov 30; 131(5):966-79.
    View in: PubMed
  21. Kleijnen MF, Roelofs J, Park S, Hathaway NA, Glickman M, King RW, Finley D. Stability of the proteasome can be regulated allosterically through engagement of its proteolytic active sites. Nat Struct Mol Biol. 2007 Dec; 14(12):1180-8.
    View in: PubMed
  22. Wang M, Zhou X, Li F, Huckins J, King RW, Wong ST. Novel cell segmentation and online SVM for cell cycle phase identification in automated microscopy. Bioinformatics. 2008 Jan 1; 24(1):94-101.
    View in: PubMed
  23. Bentley AM, Normand G, Hoyt J, King RW. Distinct sequence elements of cyclin B1 promote localization to chromatin, centrosomes, and kinetochores during mitosis. Mol Biol Cell. 2007 Dec; 18(12):4847-58.
    View in: PubMed
  24. Wang M, Zhou X, King RW, Wong ST. Context based mixture model for cell phase identification in automated fluorescence microscopy. BMC Bioinformatics. 2007; 30:8-32.
  25. Crosas B, Hanna J, Kirkpatrick DS, Zhang DP, Tone Y, Hathaway NA, Buecker C, Leggett DS, Schmidt M, King RW, Gygi SP, Finley D. Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities. Cell. 2006 Dec 29; 127(7):1401-13.
    View in: PubMed
  26. Hanna J, Hathaway NA, Tone Y, Crosas B, Elsasser S, Kirkpatrick DS, Leggett DS, Gygi SP, King RW, Finley D. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell. 2006 Oct 6; 127(1):99-111.
    View in: PubMed
  27. Kirkpatrick DS, Hathaway NA, Hanna J, Elsasser S, Rush J, Finley D, King RW, Gygi SP. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat Cell Biol. 2006 Jul; 8(7):700-10.
    View in: PubMed
  28. Stern HM, Murphey RD, Shepard JL, Amatruda JF, Straub CT, Pfaff KL, Weber G, Tallarico JA, King RW, Zon LI. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol. 2005 Dec; 1(7):366-70.
    View in: PubMed
  29. Shi Q, King RW. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature. 2005 Oct 13; 437(7061):1038-42.
    View in: PubMed
  30. Lorang J, King RW. Cytological profiling: providing more haystacks for chemists' needles. Genome Biol. 2005; 6(8):228.
    View in: PubMed
  31. Hathaway NA, King RW. Dissecting cell biology with chemical scalpels. Curr Opin Cell Biol. 2005 Feb; 17(1):12-9.
    View in: PubMed
  32. Hoyt J, King RW. Adenoviral expression of reporter proteins for high-throughput cell-based screening. Methods Mol Biol. 2005; 310:187-95.
    View in: PubMed
  33. Stern HM, Murphey RD, Shepard JL, Amatruda JF, Straub CT, Pfaff KL, Weber G, Tallarico JA, King RW, Zon LI. Persynthamide suppresses bmyb-associated cell cycle defects via the intra-S checkpoint. Nature Chem. Biol. 2005; 1:366-370.
  34. Salic A, King RW. Identifying small molecule inhibitors of the ubiquitin-proteasome pathway in Xenopus egg extracts. Methods Enzymol. 2005; 399:567-85.
    View in: PubMed
  35. Lorang J, King RW. Cytological profiling: Identifying more haystacks for chemists' needles. 2005; 6:228.
  36. Tochtrop GP, King RW. Target identification strategies in chemical genetics. Comb Chem High Throughput Screen. 2004 Nov; 7(7):677-88.
    View in: PubMed
  37. Verma R, Peters NR, D'Onofrio M, Tochtrop GP, Sakamoto KM, Varadan R, Zhang M, Coffino P, Fushman D, Deshaies RJ, King RW. Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain. Science. 2004 Oct 1; 306(5693):117-20.
    View in: PubMed
  38. Cheng D, Yadav N, King RW, Swanson MS, Weinstein EJ, Bedford MT. Small molecule regulators of protein arginine methyltransferases. J Biol Chem. 2004 Jun 4; 279(23):23892-9.
    View in: PubMed
  39. Tochtrop G, King RW. Target identification strategies for chemical genetics. J. Comb. Chem. 2004; 7:677-688.
  40. King RW. Roughing up Smoothened: chemical modulators of hedgehog signaling. J Biol. 2002 Nov 6; 1(2):8.
    View in: PubMed
  41. Clemons PA, Koehler AN, Wagner BK, Sprigings TG, Spring DR, King RW, Schreiber SL, Foley MA. A one-bead, one-stock solution approach to chemical genetics: part 2. Chem Biol. 2001 Dec; 8(12):1183-95.
    View in: PubMed
  42. Walling LA, Peters NR, Horn EJ, King RW. New technologies for chemical genetics. J Cell Biochem Suppl. 2001; Suppl 37:7-12.
    View in: PubMed
  43. Haggarty SJ, Mayer TU, Miyamoto DT, Fathi R, King RW, Mitchison TJ, Schreiber SL. Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem Biol. 2000 Apr; 7(4):275-86.
    View in: PubMed
  44. King RW. Chemistry or biology: which comes first after the genome is sequenced? Chem Biol. 1999 Dec; 6(12):R327-33.
    View in: PubMed
  45. Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SL, Mitchison TJ. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science. 1999 Oct 29; 286(5441):971-4.
    View in: PubMed
  46. Yu H, Peters JM, King RW, Page AM, Hieter P, Kirschner MW. Identification of a cullin homology region in a subunit of the anaphase-promoting complex. Science. 1998 Feb 20; 279(5354):1219-22.
    View in: PubMed
  47. Peters JM, King RW, Deshaies RJ. Cell cycle control by ubiquitin-dependent proteolysis. Ubiquitin and the Biology of the Cell, Peters JM, Harris JR, and Finley D, Eds. 1998; 345-387.
  48. King RW, Lustig KD, Stukenberg PT, McGarry TJ, Kirschner MW. Expression cloning in the test tube. Science. 1997 Aug 15; 277(5328):973-4.
    View in: PubMed
  49. Stukenberg PT, Lustig KD, McGarry TJ, King RW, Kuang J, Kirschner MW. Systematic identification of mitotic phosphoproteins. Curr Biol. 1997 May 1; 7(5):338-48.
    View in: PubMed
  50. Lustig KD, Stukenberg PT, McGarry TJ, King RW, Cryns VL, Mead PE, Zon LI, Yuan J, Kirschner MW. Small pool expression screening: A novel strategy for the identification of genes involved in cell cycle control, apoptosis, and early development. Meth. Enzym. 1997; 283:83-99.
  51. Kirschner MW, King RW, Peters JM. Assay and reagents for detecting inhibitors of ubiquitin-dependent degradation of cell-cycle regulatory proteins. 1997.
  52. Mohrig JR, Rosenberg R, Apostol JW, Bastienaansen M, Evans JW, Franklin SJ, Frisbie CD, Fu SS, Hamm ML, Hirose CB, Hundstad DA, James TL, King RW, Larson CJ, Latham HA, Owen DA, Stein KA ,Warnet R. Diastereoselectivity of enolate anion protonation. H/D exchange of ƒÒ-substituted ethyl butanoates in ethanol-d. J. Amer. Chem. Soc. 1997; 119:479-486.
  53. King RW, Deshaies RJ, Peters JM, Kirschner MW. How proteolysis drives the cell cycle. Science. 1996 Dec 6; 274(5293):1652-9.
    View in: PubMed
  54. Peters JM, King RW, Höög C, Kirschner MW. Identification of BIME as a subunit of the anaphase-promoting complex. Science. 1996 Nov 15; 274(5290):1199-201.
    View in: PubMed
  55. King RW, Glotzer M, Kirschner MW. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol Biol Cell. 1996 Sep; 7(9):1343-57.
    View in: PubMed
  56. Yu H, King RW, Peters JM, Kirschner MW. Identification of a novel ubiquitin-conjugating enzyme involved in mitotic cyclin degradation. Curr Biol. 1996 Apr 1; 6(4):455-66.
    View in: PubMed
  57. King RW, Peters JM, Tugendreich S, Rolfe M, Hieter P, Kirschner MW. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell. 1995 Apr 21; 81(2):279-88.
    View in: PubMed
  58. King RW, Lustig KD, Stukenberg PT, Kirschner MW. Improved method of expression cloning. 1995.
  59. King, RW. Biochemical characterization of the cyclin B ubiquitin conjugation system. 1995.
  60. King RW, Jackson PK, Kirschner MW. Mitosis in transition. Cell. 1994 Nov 18; 79(4):563-71.
    View in: PubMed
  61. Holloway SL, Glotzer M, King RW, Murray AW. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell. 1993 Jul 2; 73(7):1393-402.
    View in: PubMed
  62. Mohrig JR, Fu SS, King RW, Warnet RW, Gustafson G. Stereochemistry of nucleophilic conjugate addition. Addition of ethanol-d and 2-methyl-2-propanethiol-d to ethyl crotonate. J. Am. Chem. Soc. 1990; 112:3665-3667.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
King's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_